维康药业
(300878)
| 流通市值：40.40亿 | | | 总市值：40.58亿 |
| 流通股本：1.44亿 | | | 总股本：1.45亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 178,344,442.66 | 126,158,518.77 | 69,661,950.22 | 225,272,638.73 |
| 营业总成本 | 199,655,947.94 | 141,312,717.22 | 59,200,096.66 | 324,809,022.52 |
| 其他经营收益 | | | | |
| 营业利润 | -15,594,975.85 | -16,766,966.28 | 9,439,407.8 | -201,543,423.63 |
| 利润总额 | -19,507,159.31 | -20,490,692.93 | 5,720,488.87 | -208,475,111.8 |
| 净利润 | -22,815,976.83 | -22,209,858.75 | 1,843,165 | -229,731,806.47 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -22,815,976.83 | -22,209,858.75 | 1,843,165 | -229,731,806.47 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 444,933,898.88 | 431,553,851.34 | 430,437,793.16 | 383,250,258.53 |
| 非流动资产: | | | | |
| 非流动资产合计 | 822,422,001.04 | 836,140,809.39 | 857,029,736.33 | 867,978,415.3 |
| 资产总计 | 1,267,355,899.92 | 1,267,694,660.73 | 1,287,467,529.49 | 1,251,228,673.83 |
| 流动负债: | | | | |
| 流动负债合计 | 313,372,497.1 | 312,583,469.94 | 221,271,046.47 | 185,424,481.36 |
| 非流动负债: | | | | |
| 非流动负债合计 | 53,073,188.63 | 53,594,858.52 | 140,645,978.9 | 142,078,001.45 |
| 负债合计 | 366,445,685.73 | 366,178,328.46 | 361,917,025.37 | 327,502,482.81 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 887,359,909.62 | 888,182,220.52 | 912,178,248.81 | 910,437,824.45 |
| 股东权益合计 | 900,910,214.19 | 901,516,332.27 | 925,550,504.12 | 923,726,191.02 |
| 负债和股东权益合计 | 1,267,355,899.92 | 1,267,694,660.73 | 1,287,467,529.49 | 1,251,228,673.83 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 133,259,772.33 | 88,617,522.76 | 42,200,887.42 | 287,565,395.25 |
| 经营活动现金流出小计 | 166,060,388.49 | 113,241,601.3 | 63,097,829.15 | 220,475,938.17 |
| 经营活动产生的现金流量净额 | -32,800,616.16 | -24,624,078.54 | -20,896,941.73 | 67,089,457.08 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 24,866,081.82 | 24,866,081.82 | 63,301 | 44,713,315.68 |
| 投资活动现金流出小计 | 21,196,614.75 | 19,289,143.66 | 8,511,396.02 | 87,171,199.32 |
| 投资活动产生的现金流量净额 | 3,669,467.07 | 5,576,938.16 | -8,448,095.02 | -42,457,883.64 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 139,000,000 | 139,000,000 | 84,000,000 | 65,420,365.13 |
| 筹资活动现金流出小计 | 73,953,323.05 | 72,421,525.6 | 10,613,606.13 | 216,476,072.79 |
| 筹资活动产生的现金流量净额 | 65,046,676.95 | 66,578,474.4 | 73,386,393.87 | -151,055,707.66 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 35,915,527.86 | 47,531,334.02 | 44,041,357.12 | -126,424,134.22 |
| 期末现金及现金等价物余额 | 163,100,727.43 | 174,716,533.59 | 181,226,556.69 | 127,185,199.57 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 47,531,334.02 | - | -126,424,134.22 |